<DOC>
	<DOC>NCT02632851</DOC>
	<brief_summary>This observational, non-interventional multicentric study compares the inhalation therapy on patients suffering on respiratory tract infections and/or acute bronchitis between Ectoin inhalation solution and Pari NaCl (0.9%) inhalation solution</brief_summary>
	<brief_title>Treatment of Respiratory Tract Infection and/or Acute Bronchitis With Ectoin Inhalation Solution</brief_title>
	<detailed_description>The assessment focuses on the bronchitis Severity Score (BSS) for standardized use in clinical studies with the outcome criteria of cough, sputum production, rales/rhonchi, chest pain during coughing and dysnoea</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Respiratory Aspiration</mesh_term>
	<mesh_term>Bronchitis</mesh_term>
	<mesh_term>Acute Disease</mesh_term>
	<mesh_term>Dyspnea</mesh_term>
	<mesh_term>Respiratory Tract Infections</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>according to instruction for use according to instruction for use</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>inhalation</keyword>
	<keyword>isotonic saline</keyword>
	<keyword>NaCl solution 0.9 %</keyword>
	<keyword>Ectoin</keyword>
	<keyword>bronchitis</keyword>
	<keyword>respiratory tract infection</keyword>
</DOC>